Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

about

Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.PET imaging in multiple sclerosis.Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.

P2860

Q30712257-3855CEDE-1875-480B-944C-793236E3281D Q38210272-736D107E-4A39-496A-86CA-B8F9AB281737 Q50726630-8BAE3DE0-FAB2-4F61-A704-77337206C19E

P2860

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

Item

http://www.wikidata.org/entity/Q51236987

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

@en

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

@nl

type

Item

label

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

@en

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

@nl

prefLabel

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

@en

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

@nl

P1476

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

@en

P2093

M Bongianni

http://www.w3.org/2001/XMLSchema#string

M R Bianchi

http://www.w3.org/2001/XMLSchema#string

M Turatti

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis.

Proposed diagnostic criteria and nosology of acute transverse myelitis.

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Revised diagnostic criteria for neuromyelitis optica.

Will Rogers phenomenon in multiple sclerosis.

Quantitative T2' imaging in patients with clinically isolated syndrome

P304

336-344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12123

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Gianluigi Zanusso

Alberto Gajofatto

Salvatore Monaco

Maria Donata Benedetti

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236101840

http://www.w3.org/2001/XMLSchema#string

P698

23550839

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

about

P2860

P2860

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921